trending Market Intelligence /marketintelligence/en/news-insights/trending/mrxjvbuvpxnt1yjtsxdryq2 content esgSubNav
In This List

Depomed changes name to Assertio Therapeutics

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Depomed changes name to Assertio Therapeutics

Depomed Inc. said it changed its name to Assertio Therapeutics Inc. following shareholder approval.

In connection with the name change, Depomed's shares will trade on the Nasdaq Global Select Market under the new symbol ASRT beginning Aug. 15.

According to the company, the Assertio name reflects its renewed commitment to the advancement of patient care in the core areas of neurology, orphan and specialty medicines.

Depomed also completed the relocation of its corporate headquarters from Newark, Calif., to Lake Forest, Ill.